Aleukemic Mast Cell Leukemia with Abnormal Immunophenotype and C-kit Mutation D816V

References

• Valent, P., Horny, H.-P., Li, C., Longley, B., Metcalfe, D., Parwaresch, R. and Bennett, J. (2001) Mastocytosis. In WHO Classification of Tumours. Pathology and Genetics. Tumours of Haematopoetic and Lymphoid Tissues, edited by E. Jaffe, N. Harris, H. Stein and J.W. Vardiman. Lyon: IARC Press.
   Google Scholar
• Valent, P., Horny, H.P., Escribano, L., Longley, B.J., Li, C.Y., Schwartz, LB., et al. (2001) "Diagnostic criteria and classification of mastocytosis: a consensus proposal", Leukemia Research, 25, 603–625.
   PubMed Web of Science ®Google Scholar
• Kanakura, Y., Furitsu, T., Tsujimura, T., Butterfield, J.H., Ashman, L.K., Ikeda, H., et al. (1994) "Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line", Leukemia, 8\(Suppl 1), S18 — S22.
   PubMed Web of Science ®Google Scholar
• Sotlar, K., Saeger, W., Stellmacher, F., Jackle, S., Valent, P. and Horny, H.-P. (2004) "Occult mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma (SM-AHNMD)", American Journal of Clinical Pathology (submitted).
   Google Scholar
• Valent, P. (2002) "Mast cell leukemia—a rare form of myeloid leukemia", Wiener Klinische Wochenschrift, 114, 173 — 174.
   PubMed Web of Science ®Google Scholar
• Joachim, G. (1906) "Uber Mastzellenleukamien", Deutsches Arch iv fur Klinische Medizin, 87, 437.
   Google Scholar
• Travis, W.D., Li, C.Y., Hoagland, H.C., Travis, L.B. and Banks, P.M. (1986) "Mast cell leukemia: report of a case and review of the literature", Mayo Clinic Proceedings, 61, 957–966.
   PubMed Web of Science ®Google Scholar
• Popa, G. and Iordacheanu, L. (1977) "Mast cell leukemia", Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi., 81, 519— 520.
   PubMedGoogle Scholar
• Pauls, JD., Brems, J., Pockros, P.J., Saven, A., Wagner, R.L., Weber, R., et al. (1999) "Mastocytosis: diverse presentations and outcomes", Archives of Internal Medicine, 159, 401 —405.
   PubMed Web of Science ®Google Scholar
• Le Cam, MT., Wolkenstein, P., Cosnes, A., Bocquet, H., Gaulard, P., Tulliez, M., et al. (1997) "Acute mast cell leukemia disclosed by vasomotor flushing", Annales de Dermatologie et de Venereologie, 124, 621–622.
   PubMed Web of Science ®Google Scholar
• Kyriakou, D., Kouroumalis, E., Konsolas, J., Oekonomaki, H., Tzardi, M., Kanavaros, P., et al. (1998) "Systemic mastocytosis: a rare cause of noncirrhotic portal hypertension simulating auto-immune cholangitis—report of four cases", American Journal of Gastroenteroly, 93, 106 — 108.
   Google Scholar
• Kimura, A., Tanaka, R., Taketomi, Y., Dohy, H., Fujimura, K., Kamada, N., et al. (1979) "A case of mastocytoma with leukemic manifestation of its immature form in the terminal stage", Rinsho Ketsueki, 20, 1137–1146.
   Google Scholar
• Horny, H.P., Krokowski, M., Feller, AC., Hintze, G., Sotlar, K. and Valent, P. (2002) "Aleukemic mast cell leukemia (formerly: "malignant mastocytosis"): an extremely rare form of leukemia. A case report and simultaneously a contribution to revised classifica-tion of mastocytosis", Wiener Klinische Wochenschrift, 114, 222–228.
   Google Scholar
• Friedman, B., Will, J., Freiman, D. and Braunstein, H. (1958) "Tissue mast cell leukemia", Blood, 13, 70–78.
   PubMed Web of Science ®Google Scholar
• Escribano, L., Orfao, A., Villarrubia, J., Martin, F., Madruga, Cuevas, M., et al. (1997) "Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia", Cytometry, 30, 98–102.
   PubMedGoogle Scholar
• Efrati, P., Klajman, A. and Spitz, H. (1957) "Malignant mastocy-tosis with leukemia-like manifestations", Blood, 12, 869–882.
   Google Scholar
• Daniel, MT., Flandrin, G. and Bernard, J. (1975) "Acute mast-cell leukemia. Cytochemical and ultrastructural study, about a parti-cular case", Nouvelle Revue Francaise d'Hematologie, 15, 319–332.
   Web of Science ®Google Scholar
• Dalton, R., Chan, L., Batten, E. and Eridani, S. (1986) "Mast cell leukaemia: evidence for bone marrow origin of the pathological clone", British Journal of Haematology, 64, 397–406.
   PubMed Web of Science ®Google Scholar
• Coser, P., Quaglino, D., De Pasquale, A., Colombetti, V. and Prinoth, O. (1980) "Cytobiological and clinical aspects of tissue mast cell leukaemia", British Journal of Haematology, 45, 5–12.
   PubMed Web of Science ®Google Scholar
• Clancy, R.L., Gauldie, J., Vallieres, M., Bienenstock, J., Day, R.P. and Pineo, G.F. (1976) "An approach to immunotherapy using antibody to IgE in mast cell leukemia", Cancer, 37, 693–696.
   Google Scholar
• Chen, T.Y., Chen, J.S., Huang, W.T., Su, W.C. and Tsao, C.J. (2003) "Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation", Bone Marrow Transplantion, 32, 111 — 114.
   Google Scholar
• Butterfield, J.H., Weiler, D., Dewald, G. and Gleich, G.J. (1988) "Establishment of an immature mast cell line from a patient with mast cell leukemia", Leukemia Research, 12, 345–355.
   Google Scholar
• Brinkmann, E. (1959) "Mastzellenretikulose (Gewebsbasophilom) mit histaminbedingten Flush und Übergang in Gewebsbasophilen-Leukamie", Schweizer Medizinsche Wochenschrift, 89, 1046–1048.
   PubMedGoogle Scholar
• Baghestanian, M., Bankl, H., Sillaber, C., Beil, W.J., Radaszlde-wicz, T., Fureder, W., et al. (1996) "A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone", Leukemia, 10, 159–166.
   PubMed Web of Science ®Google Scholar
• Samorapoompichit, P., Steiner, M., Lucas, T., Wachtler, F., Schedled, A., Sperr, W.R., et al. (2003) "Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugs", Leukemia & Lymphoma, 44, 509–515.
   PubMed Web of Science ®Google Scholar
• Kluin-Nelemans, H.C., Jansen, J.H., Breukelman, H., Wolthers, B.G., Kluin, P.M., Kroon, H.M., et al. (1992) "Response to interferon alfa-2b in a patient with systemic mastocytosis", New England Journal of Medicine, 326, 619–623.
   PubMed Web of Science ®Google Scholar
• Tefferi, A., Li, C.-Y., Butterfield, J.H. and Hoagland, H.C. (2001) "Treatment of systemic mast-cell disease with cladribine", New England Journal of Medicine, 344, 307 — 309.
   Web of Science ®Google Scholar
• Kluin-Nelemans, H., Oldhoff, J., Van Doormaal, J., Van 't Wout, J., Verhoef, G., Gerrits, W., et al. (2003) "Cladribine therapy for systemic mastocytosis", Blood, 102, 4270–4276.
   PubMed Web of Science ®Google Scholar
• Akin, C., Brockow, K., D'Ambrosio, C., Kirshenbaum, AS., Ma, Y., Longley, B.J., et al. (2003) "Effects of tyrosine kinase inhibitor 5TI571 on human mast cells bearing wild-type or mutated c-kit", Experimental Hematology, 31, 686–692.
   PubMed Web of Science ®Google Scholar
• Ma, Y., Zeng, S., Metcalfe, D., Akin, C., Dimitrijevic, S., Butterfield, J.H., et al. (2003) "The c-KIT mutation causing human mastocytosis is resistent to STI571 and other KIT kinase inhibitors: kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations", Blood, 99, 1741–1744.
   Google Scholar
• Pardanani, A., Elliott, M., Reeder, T., Li, C., Baxter, E., Cross, N., et al. (2003) "Imitinib for systematic mast-cell disease", Lancet, 362, 535–536.
   PubMed Web of Science ®Google Scholar
• Horny, H.P. and Valent, P. (2001) "Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings", Leukemia Research, 25, 543–551.
   Google Scholar
• Horny, H.-P., Greschniok, A., Jordan, J.H., Menke, D. and Valent, P. (2003) "Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohisto-chemical and morphometric study", Journal of Clinical Pathology, 56, 103–106.
   PubMed Web of Science ®Google Scholar
• Davies, S., Jones, E., Bodian, D., Barclay, A. and van der Merve, P. (1993) "Analysis of the structure and interactions of CD2", Biochemical Society Transactions, 21, 952–958.
   PubMed Web of Science ®Google Scholar
• Valent, P. and Bettelheim, P. (1992) "Cell surface structures on human basophils and mast cells: Biochemical and functional characterization", Advances in Immunology, 52, 333–421.
   PubMed Web of Science ®Google Scholar
• Schernthaner, G.H., Jordan, J.H., Ghannadan, M., Agis, H., Bevec, D., Nunez, R., et al. (2001) "Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells", Blood, 98, 3784— 3792.
   Google Scholar
• Pardanani, A., Kimlinger, T., Reeder, T., Li, C.-Y. and Tefferi, A. (2003) "Differential expression of CD2 on neoplastic mast cells in patients with systemic mast cell disease with and without an associated clonal haematological disorder", British Journal of Haematology, 120, 691 — 694.
   Web of Science ®Google Scholar
• Falini, B., Flenghi, L., Pileri, S., Gambacorta, M., Bigerna, B., Durkop, H., et al. (1993) "PG-MI: a new monoclonal antibody directed against a fixative-resistant epitope on the marcophage-restricted form of the CD68 molecule", American Journal of Pathology, 142, 1359 — 1372.
   Google Scholar
• Horny, H.-P., Ruck, P., Xiao, J. and Kaiserling, E. (1993) "Immunoreactivity of normal and neoplastic human tissue mast cells with macrophage-associated antibodies, with special reference to the recently developed monoclonal antibody PG-MI", Human Pathology, 24, 355 — 358.
   Web of Science ®Google Scholar
• Valent, P., Spanblochl, E., Bankl, H.C., Sperr, W.R., Marosi, C., Pirc-Danoewinata, H., et al. (1994) "Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis", Blood, 84, 4322–4332.
   PubMed Web of Science ®Google Scholar
• Valent, P., Escribano, L., Parwaresch, R.M., Schemmel, V., Schwartz, L.B., Sotlar, K., et al. (1998) "Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998", International Archives of Allergy and Immunology, 120, 1 — 7.
   Web of Science ®Google Scholar
• Boissan, M., Feger, F., Guillosson, J.J. and Arock, M. (2000) "c-Kit and c-kit mutations in mastocytosis and other hematological diseases", Journal of Leukocyte Biology, 67, 135 — 148.
   Google Scholar
• Longley, B.J., Tyrrell, L., Lu, S.Z., Ma, Y.S., Langley, K., Ding, T.G., et al. (1996) "Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm", Nature Genetics, 12, 312 —314.
   PubMed Web of Science ®Google Scholar
• Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., et al. (1993) "Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product", Journal of Clinical Investigation, 92, 1736 — 1744.
   Web of Science ®Google Scholar